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AngioblastThe angioblast is an embryonic endothelial cell precursor that migrates long distances to reach its ﬁnal
position, navigating by sensing attractive and repulsive cues from the environment. Members of the
semaphorin family have been implicated in controlling the behaviour of angioblast tip cells through repulsive
signalling in vitro, but their in vivo roles are less clear. Here we show that zebraﬁsh semaphorin3e (sema3e) is
expressed by endothelial cells of the dorsal aorta, primary motoneurons, and endodermal cells. Further, loss
of Sema3e leads to delayed exit of angioblasts from the dorsal aorta in ISV formation. Through transplant
analysis, we show that Sema3e acts autonomously and non-autonomously in angioblasts to modulate
interactions among themselves. The semaphorin receptors, PlexinD1 and PlexinB2, are expressed by
zebraﬁsh angioblasts. Loss of plxnB2 results in delayed ISV sprouting identical to that seen in sema3e
morphants, while loss of plexinD1 in out of bounds (obd) mutants results in precocious ISV sprouting. Loss of
either sema3e or plxnB2 in obd mutants generates an intermediate phenotype, suggesting that PlxnD1 and
Sema3e/PlxnB2 antagonize each other to control timing of ISV sprouting. Consistent with this observation,
we show that PlxnB2 acts cell autonomously in endothelial cells. This suggests a model where multiple
semaphorin–plexin interactions control angioblast sprouting behaviour.© 2009 Elsevier Inc. All rights reserved.IntroductionWe are interested in determining the signals that pattern the
development of the vasculature. Zebraﬁsh intersegmental vessels
(ISVs) are an excellent system to study how alterations in signals
result in subtle changes in cell morphology and behaviour because
they are only one cell in diameter and three or four cells in length
(Childs et al., 2002; Siekmann and Lawson, 2007). Furthermore,
transgenic zebraﬁsh expressing GFP in angioblasts can be used to trace
vascular development in vivo in the transparent embryo (Choi et al.,
2007; Cross et al., 2003; Lawson and Weinstein, 2002).
During zebraﬁsh development, angioblasts are speciﬁed in the
bilateral lateral posterior mesoderm, after which they migrate to the
midline where they undergo tubulogenesis to form the dorsal aorta
and posterior cardinal vein by the 17 somite stage (17S) (Eriksson and
Lofberg, 2000). Angioblasts then sprout from the dorsal aorta to form
the ISVs at 20S in an anterior to posterior wave, following the
developmental maturation of somites. The ISVs grow dorsally from
the dorsal aorta, restrictedmedially and dorsally by the notochord and
laterally, rostrally, and caudally by the somites. When the ISVs reach
the dorsal region of the embryo, the cells take on a “T”-shapedmite stage; hpf, hours post
, wt.
l rights reserved.morphology and fuse to adjacent cells to form the dorsal longitudinal
anastomotic vessel (DLAV) (Childs et al., 2002).
Migrating angioblasts assume one of two cellular identities: a tip
cell or a stalk cell (Gerhardt et al., 2003; Siekmann and Lawson, 2007).
The tip cell is analogous to the axon growth cone as it senses the
extracellular environment for attractive and repulsive growth cues
through ﬁlopodial projections. The stalk cell is non-migratory, non-
proliferative, undergoes lumenization, and has a decreased number of
ﬁlopodia. The stalk cell develops from the tip cell after it reaches its
ﬁnal position. In the zebraﬁsh, once ISV tip cells reach the dorsal
aspect of the embryo, cells from adjacent ISVs come into contact with
each other and reciprocal signalling through the Notch signalling
pathway suppresses ﬁlopodial extension and transforms tip cells to a
stalk cell identity (Hellstrom et al., 2007; Leslie et al., 2007; Siekmann
and Lawson, 2007).
Some of the signals guiding the migration of ISV angioblasts have
been determined. We previously reported the out of bounds (obd)
zebraﬁsh genetic mutant with a guidance defect resulting in
precocious and spatially unrestricted migration of angioblasts from
the dorsal aorta as early as 17S, together with the formation of ectopic
connections among vessels (Childs et al., 2002). We identiﬁed the
genetic lesion in obd mutants by positional cloning and found a
mutation in the vascular-speciﬁc plexinD1 (plxnD1) receptor (Torres-
Vazquez et al., 2004). Mouse embryos deﬁcient for PlxnD1 have a
similar phenotype and also exhibit excessive ISV branching (Gitler et
al., 2004; Gu et al., 2005). Plexins serve as receptors for semaphorin
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ﬁve classes of semaphorin ligands known in vertebrates (Eichmann et
al., 2005; Takahashi et al., 1999; Tamagnone et al., 1999;Winberg et al.,
1998). Of these, PlxnA2, PlxnB1, PlxnB2, PlxnB3, PlxnD1, Sema3a and
Sema3c are expressed in endothelial cells (Banu et al., 2006; Basile et
al., 2004; Herzog et al., 2005; Serini et al., 2003; Toyofuku et al., 2007).
Semaphorin–PlxnD1 signalling is thought to contribute to the ﬁne
behaviour of angioblast tip cells as they migrate by the transduction of
repulsive signals. Semaphorin 3E (Sema3E) is a secreted semaphorin
that is activated by furin proteolytic cleavage and dimerization
(Adams et al., 1997; Christensen et al., 2005). To date, most work on
Sema3E has concentrated on its role in nervous system development
where it repulses retinal axons (Steffensky et al., 2006; Steinbach et
al., 2002), hippocampal axons (Pozas et al., 2001), and sensory axons
(Miyazaki et al., 1999a, b). Interestingly, Sema3E exerts different
responses in different PlxnD1-expressing neuronal populations
depending on the presence or absence of the Neuropilin-1 (Nrp1)
co-receptor. In corticofugal and striatonigral neurons, Sema3E/PlxnD1
signalling acts repulsively in the absence of Nrp1, and acts attractively
on subiculo-mamillary neurons that express Nrp1 (Chauvet et al.,
2007). Sema3e also plays a similar role in vascular development.
Expression of Sema3e in PlxnD1-expressing cultured endothelial cells
collapses ﬁlopodia, while misexpression in the chick somite repulses
the growth of endogenous vessels (Gu et al., 2005). PlexinD1 binding
to Sema3E is neuropilin-independent since Sema3E binds mouse ISV
cells in the absence of Nrp, and deletion of the semaphorin binding
domain of Nrp1 does not affect ISV patterning (Gu et al., 2005). Thus,
it has been proposed that Sema3E is the primary repulsive ligand for
PlxnD1 in ISV patterning independent of Nrp1 (Gu et al., 2005).
Interestingly, other studies have shown that cleaved and dimerized
Sema3E promotes the migration of endothelial cells in vitro
(Christensen et al., 2005), suggesting that Sema3E can also act as an
attractant to endothelial cells in a context dependent manner.
PlxnB2 is also expressed in endothelial cells (Toyofuku et al.,
2007), however, its role in vascular development has not been
explored. B-type plexins differ from other members of the plexin
family due to the presence of a PDZ-binding motif in their cytoplasmic
C-terminus that mediates the physical interaction with two guanine
nucleotide exchange factors (GEFs): PDZ-RhoGEF and Leukemia-
associated Rho GEF (LARG) (Aurandt et al., 2002; Perrot et al., 2002;
Swiercz et al., 2002). Like semaphorins, PlxnB2 undergoes extra-
cellular proteolytic cleavage to increase ligand binding afﬁnity
(Artigiani et al., 2003). Previous studies have shown that PlxnB2
controls the migration, patterning, differentiation and proliferation of
granule cells in the cerebellum through its high afﬁnity ligand Sema4c
(Deng et al., 2007; Friedel et al., 2007). It also promotes the outgrowth
of neurites in primary cerebellar neurons in mice and mediates cell
aggregation (Hartwig et al., 2005).
Our previous work with PlxnD1 suggested that it, along with its
Sema3a2 ligand, is involved in the timing of angioblast exit from the
dorsal aorta to form the ISVs (Torres-Vazquez et al., 2004). Here we
show that Sema3e plays a novel autocrine role in the promotion of ISV
sprouting in zebraﬁsh. Further, we have identiﬁed PlxnB2 as a plexin
that genetically interacts with Sema3e in the promotion of angioblast
exit. We also show genetic evidence that Sema3e/PlxnB2 and PlxnD1
modulate the timing of angioblast exit through two independent
pathways.
Materials and methods
Embryo generation and staging
Zebraﬁsh embryos were raised at 28.5 °C according to Westerﬁeld
(1995) in E3 embryo buffer and staged according to Kimmel et al.
(1995). To block pigment formation, 0.003% phenylthiocarbamide
(PTU; Sigma, St. Louis, MO) was added to the embryo buffer at 4 hourspost fertilization (hpf). Transgenic and mutant zebraﬁsh lines have
been previously described: Tg(kdr:GFP)la116 (Choi et al., 2007), Tg
(ﬂi1a:EGFP)y1 (Lawson and Weinstein, 2002), obdfov1b, and obdfv109
(Childs et al., 2002).
sema3e and plxnB2 cloning and in situ hybridization
Full length coding sequence for sema3e was obtained by identify-
ing the translational start site in the partial 5′ sema3e clone
AW280261. To obtain 3′ sequence, sema3e was ampliﬁed from a
50 hpf RACE library (Clontech, Mountain View, CA) using the
Advantage 2 PCR system (Clontech) and the primers 5′-GGA GCT
GAA CAG GAC GTG GGT GTT CCA GG-3′ and 5′-CCA TCC TAA TAC GAC
TCA CTA TAG GGC-3′ followed by nested ampliﬁcation with 5′-GGA
GAG GGC CGT CTG CAG CAA TAC ACC ATG-3′ and 5′-ACT CAC TAT AGG
GCT CGA GCG GC-3′. This resulted in a 2.7 kb fragment containing
2.1 kb coding sequence and 0.6 kb of 3′ untranslated region, which has
been deposited in GenBank under accession EF656360. Template for
in vitro transcriptionwas obtained by digestion of this clonewith XbaI
(Invitrogen, Carlsbad, CA) and transcriptionwith SP6 RNA polymerase
(Promega, Madison, WI).
We identiﬁed zebraﬁsh plxnB2 from the EST clones CT675855,
DN857106, EB955063, and CD597409. The primers 5′-ATG CAT TCA
TCA GCC AGA GC-3′ and 5′-TGG CAG TCA TGG CTTT GGC A-3′ were
used to generate a 872 bp fragment which was subcloned into pCRII
(Invitrogen) and used as a template for an in situ probe. In situ
hybridization was performed as above. Complete plxnB2 coding
sequencewas identiﬁed using predicted sequence from ENSEMBL, and
ampliﬁed from cDNA using the primers 5′-ATG GCG TGG AGG GCC
CTG-3′ and 5′-C TAA AGG TCG GTG ACT TTA TTC TCC-3′ generating a
5.6 kb fragment which has been deposited in GenBank under
accession number EU743740.
Whole-mount in situ hybridization was performed as described in
Jowett and Lettice (1994). For photography, embryos were embedded
in 3% methylcellulose and photographed using a Zeiss Axiocam HRc.
For sectioning, embryos were embedded in JB4 medium (Poly-
sciences, Warrington, PA) and sectioned at 7 μM using a Leica
microtome.
Morpholino and DNA injections
Morpholinos (MO) against the sema3e start codon (sema3eATG;
ATG underlined) 5′-TGAAAGTCCACACACCCCACGCCAT-3′ or exon 3/
intron 3 splice boundary (sema3ee3i3) 5′-AATATCAGCTTTACCTTC-
TCTCTGC-3′ were obtained from Gene Tools LLC (Corvallis, OR).
Efﬁcacy of sema3ee3i3 splice morpholino was determined by RT-PCR
using the forward primer 5′-TCCTGTACTCCCTCAATCTG-3′ and reverse
primer 5′-CATGCCAGCAGATGAGTGCT-3′, resulting in complete mis-
splicing at a dose of 1.9 ng per embryo (Supplemental Fig. 1). The
sema3eATGmorpholino was used at a dose of 3.9 ng. Morpholinos were
diluted in 0.3× Danieau solution and injected into 1–8 cell zebraﬁsh
embryos. To assess non-speciﬁc cell death, morpholino-injected
embryos were placed in 5 μg/mL acridine orange (Sigma) in E3
embryo buffer for 30 min. There was no off-target cell death apparent
with the sema3eATG morpholino at this dose (Supplemental Fig. 2).
Full length coding sequence for sema3ewas ampliﬁed by PCR with
primers 5′-AAA AAG CAG GCT TCA CCA TGG CGT GGG GTG TGT GGA C-
3′ and 5′-AGA AAG CTG GGT GCT ACT GTC CCG GTG TGT GT-3′
incorporating the attB1 and attB2 adapter sequences for Gateway
cloning (Invitrogen). Multisite Gateway cloning using the Tol2 kit
(Kwan et al., 2007) was used to clone lmo2:sema3e:IRES-mEGFP, kdr:
sema3e:IRES-mEGFP into pDestTol2pA2 (Kwan et al., 2007). The kdr
and 2.5 kb lmo2 promoters have been described (Choi et al., 2007;
Cross et al., 2003; Du et al., 2003; Zhu et al., 2005). For expression,
23.8 pg of circular DNA and 47.5 pg of Tol2 transposase mRNA were
injected just beneath the cell of 1–2 cell zebraﬁsh embryos.
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exon 11 splice boundary (plxnB2i10e11) 5′-GGC TCT TTG TCA TAC GCA
AAC TGG C-3′ or the exon 4/intron 4 splice boundary (plxnB2e4i4) 5′-
ATC ATT CTT AAC AGA CTT ACC GGC C-3′. Efﬁcacy of plxnB2i10e11 was
determined by RT-PCR using the primers 5′-GGC CGA TGG GTT AAAFig. 1. Dynamic expression of zebraﬁsh sema3e. (A, B). At 18 somites, sema3e is expressed in
27 hpf, continued expression is observed in a single primary motoneuron and the dorsal aor
(en). (G, H) By 48 hpf, only neural expression of sema3e is observed. Signal is seen in the otic
also observed at themidbrain–hindbrain boundary (mhb) and in developing jawstructures (j)
are lateral views, (H) is dorsal view, (J) is ventral view. Scale bar in A is 325 μm, B is 10 μm,GTA CA-3′ and 5′-TTT CTC CTT CCA CCA ACA CC-3′, resulting in
complete mis-splicing at a dose of 16 ng per embryo (Supplemental
Fig. 1). plxnB2e4i4 was injected at a dose of 12 ng per embryo and
gave an identical phenotype. Acridine orange staining revealed mild
off-target neural cell death in plxnB2i10e11 morphants (Supplementalone primary motoneuron per somite (mn) and the dorsal aorta (da). (C–F) At 24 and
ta, with expression now observed in endodermal tissue ventral to the pronephric ducts
vesicle (ov) and optic chiasm (oc); persisting through 72 hpf (I, J) where expression is
. (A, C, E, G–J) arewholemount imageswhile (B, D, F) are transverse sections. (A, C, E, G, I)
C, E, G–J is 400 μm, and D, F is 30 μm.
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TTG CTT TGC AAG AAT TG-3′) (Robu et al., 2007) did not alter the
vascular phenotype of plxnB2i10e11 morphants (data not shown),
indicating that the vascular phenotype is speciﬁc to PlxnB2 knock-
down, and not to off-target cell death. sema3e/plxnB2 double
morphants were obtained using sema3eATG and plxnB2i10e11 at
1.9 ng and 4 ng, respectively.
Counting of ISV sprouts
ISV sprouts were counted in morpholino-injected, uninjected, and
obd crosses on a Tg(kdr:GFP)la116 background at 24 hpf after light
ﬁxation in 4% PFA for 45 min. The total numbers of ISV sprouts on one
side of an embryo were counted under epi-ﬂuorescence.
Cell transplantation
For cell transplantation, Tg(kdr:GFP)la116 donor embryos were
injected with 10,000 MW rhodamine-dextran (Invitrogen) with or
without 3.9 ng of sema3eATG or 16 ng of plxnB2i10e11 morpholino and
allowed to grow in 0.3× Danieau solution. Some recipient embryosFig. 2. Intersegmental sprouting is delayed in sema3ee3i3 morphants and is precocious in ob
of angioblast sprouts observed in sema3ee3i3 morphants and obdfov1b mutants as compared
of uninjected (B, C), sema3ee3i3 morphants (D, E), and obdfov1b mutants (F, G) at 24 hpf o
500 μm.were also injected with 3.9 ng of sema3eATG or 16 ng of plxnB2i10e11
morpholino. At 30–50% epiboly, 50–100 cells were transplanted from
donor embryos into the dorsal margin of non-GFP recipient embryos
in the presence of 1× Danieau solution. Donor and recipient embryos
were then allowed to develop in 0.3× Danieau solution and 2.5×
Penicillin/Streptomycin. At 24 hpf, recipient embryos were sorted for
the presence of kdr-GFP positive endothelial cells, mounted in 0.5%
low melt agarose (Invitrogen) and photographed using a Zeiss SV11
epiﬂuorescent microscope (Carl Zeiss Inc., Thornwood, NY). Total
numbers of ISV and dorsal aorta cells were counted inwtNwt (n=342
cells from 26 embryos), wtN3e MO (n= 583 cells from 43 embryos),
3e MONwt (n= 326 cells from 40 embryos), wtNplxnB2 MO
(n= 234 cells from 17 embryos), and plxnB2 MONwt (n= 179 cells
from 20 embryos). Any errors in counting would be expected to affect
all experimental groups equally. The proportion of cells contributing
to the PCV did not differ between the various transplantation
experiments and were not included in our analyses. Each experiment
was performed at least twice to ensure reproducibility. Transplanted
embryos containing high numbers of cells of endodermal or
ectodermal originwere not included in analyses as these are potential
non-autonomous sources of Sema3e.d mutants. (A) Graphical representation of the mean number and standard deviation
to control embryos. Confocal (B, D, F) and corresponding white light images (C, E, G)
n a Tg(kdr:GFP)la116 genetic background. Scale bar in B, D, F is 100 μm and C, E, G is
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sema3e is dynamically expressed in diverse tissues
We identiﬁed the zebraﬁsh sema3e ortholog using the UCSC
Zebraﬁsh Genome Browser (http://genome.ucsc.edu). We identi-
ﬁed only a single sema3e gene in zebraﬁsh, unlike many genes
which are present in two copies in the zebraﬁsh genome.
Expression analysis by wholemount in situ hybridization showed
that sema3e was expressed in one primary motoneuron per somite,
as well as the dorsal aorta at 18S (Figs. 1A, B). At 24 hpf,
expression persisted in a single primary motoneuron per somite, as
well as in the endoderm beneath the pronephric duct at both 24
and 27 hpf (Figs. 1C–F). Vascular, endodermal, and motoneuron
expression was not observed at 48 hpf. At this time, expression
was seen in the otic vesicle and the optic chiasm (Figs. 1G, H) as
previously reported (Callander et al., 2007). Expression of sema3e
was maintained in the optic chiasm and other neural structures at
72 hpf, when expression in developing jaw structures appeared
(Figs. 1I, J).
Loss of Sema3e results in delayed ISV sprouting
To determine the role of Sema3e in the development of the
embryonic vasculature, we injected morpholino antisense oligonu-
cleotides targeted against the translational start site (sema3eATG) or
the splice junction between exon 3 and intron 3 (sema3ee3i3) into
transgenic Tg(kdr:GFP)la116 zebraﬁsh embryos expressing GFP in all
endothelial cells. Bothmorpholinos resulted in an identical phenotype
and were used interchangeably. Complete mis-splicing of sema3ewas
seen at a dose of 1.9 ng of sema3ee3i3 (Supplemental Fig. 1). Further,
cell death due to non-speciﬁc morpholino effects was assayed using
acridine orange and no increase of cell death compared to uninjected
controls was observed (Supplemental Fig. 2).
Previously, we reported that obd embryos show precocious
angioblast sprouting at 17S, when compared to wild type angio-
blasts which begin sprouting at 20S (Childs et al., 2002). As Sema3E
has been proposed to be the primary ligand for PlxnD1, we expected
that down regulation of zebraﬁsh sema3e would also result in
precocious angioblast sprouting. Thus, we counted angioblast
sprouts in sema3e morphants, obd mutants, and uninjected controls
or wild type siblings, respectively, at 24 hpf. The sprouts on one side
of the embryo were counted in uninjected embryos or sema3ee3i3
morphants on a Tg(ﬂi1:nEGFP)17 background, and wild type sibling
or obdfov1b mutants on a Tg(kdr:GFP)la116 background. At 24 hpf,
uninjected embryos had an average of 13.6± 2.8 sprouts (n= 28)
(Figs. 2A, B). sema3ee3i3 morphants showed a signiﬁcant delay in
sprouting in that they had an average of 6.1±4.3 sprouts per
embryo (n= 59) (Figs. 2A, D). This delay showed high penetrance
as 78% of sema3ee3i3 morphants had fewer than 10 angioblast
sprouts per embryo, while only 7% of control embryos had fewer
than 10 per embryo at this time. This delay is not permanent
suppression of sprouting as sema3e morphants had an equivalent
number of ISVs past the horizontal myoseptum as uninjected
controls by 30 hpf (data not shown). This delay in sprouting was
also not due to general developmental delay as the number of
somites that had formed (a measure of developmental stage) is
equal in both groups (Figs. 2C, E).
As expected, the average number of angioblast sprouts per embryo
in obdfov1b mutants was greater than that of their wild type siblings at
24 hpf (16.5±1.9 (n= 94) versus 14.2±2.3 (n= 90) sprouts per
embryo, respectively) (Figs. 2A, F, G). Thus, loss of Sema3e results in
delayed angioblast sprouting, while loss of PlxnD1 results in
precocious sprouting. These are unexpectedly opposite phenotypes
suggesting that they do not function as ligand and receptor pair in this
aspect of vascular morphogenesis.PlxnB2 genetically interacts with Sema3e
Aswe showed above, loss of PlxnD1 or Sema3e signalling results in
opposite timing of angioblast sprouting phenotypes, suggesting an
additional plexin expressed in angioblasts can act as a receptor for
Sema3e. Thus, we identiﬁed all plexin molecules from the zebraﬁsh
genome and performed an in situ hybridization screen at 24 hpf to
identify plexins expressed by endothelial cells (data not shown).
Although PlxnB1, PlxnB2, and PlxnB3 have all been reported
previously to be expressed by cultured endothelial cells (Toyofuku
et al., 2007), we did not ﬁnd expression of either plxnB1 or plxnB3 in
endothelial cells (data not shown). However, we did ﬁnd that plxnB2
is expressed ubiquitously, with increased expression in the region of
the ventral trunk (Figs. 3A, B). Thus, we chose to further examine the
potential role of PlxnB2.
To determine the function of PlxnB2 in vascular development, we
injected Tg(kdr:GFP)la116 embryos with two morpholinos against
plxnB2 (plxnB2i10e11 and plxnB2e4i4) and achieved complete mis-
splicing at doses of 16 ng and 12 ng, respectively (Supplemental Fig.
1). Non-speciﬁc cell death was determined using acridine orange and
was determined not to affect the morphant vascular phenotype as co-
injection of the plxnB2i10e11 and p53 morpholinos gave an identical
vascular phenotype as plxnB2i10e11 morpholino alone (Supplemental
Fig. 2 and data not shown). Both morpholinos gave an identical
phenotype of delayed angioblast sprouting as compared to wild type
(Figs. 3E, F, and data not shown), similar to that seen in sema3e
morphants. At 24 hpf, uninjected embryos have an average of 16.0
(±3.5) sprouts per embryo (n= 110) while plxnB2i10e11morphants
had an average of only 3.7 (±2.9) sprouts per embryo (n= 110) (Figs.
3E, F, I). This phenotype was highly penetrant as 98.1% of plxnB2i10e11
morphants had fewer than 10 angioblast sprouts per embryo
compared to only 5.5% in uninjected controls. Delayed ISV angioblast
sprouting in plxnB2i10e11 morphants was not caused by general
embryonic delay as the number of somites in uninjected controls
and plxnB2i10e11morphants were equal (Figs. 3C, D). Further, the delay
of ISV growth in plxnB2 morphants was determined by counting the
number of ISVs sprouted past the horizontal myoseptum in 30 hpf
control embryos and then determining the amount of time required
for morphants to reach the equivalent stage. Using this method, we
determined that ISV growth in plxnB2 morphants is delayed 6 h
compared to uninjected controls (data not shown).
The phenotypic similarity between plxnB2 and sema3e (Figs. 3F, G)
morphants suggests that these two molecules could be a receptor–
ligand pair. To test this, we co-injected both sema3eATG and
plxnB2i10e11 morpholinos together to observe if full knockdown of
both genes simultaneously resulted in an exacerbated sprouting
phenotype. However, co-injection of these two morpholinos resulted
in complete embryo death, even with the addition of morpholino
against p53 to block off-target cell death (data not shown). Therefore,
suboptimal doses of sema3eATG and plxnB2i10e11 morpholinos (2 ng
and 4 ng, respectively) were co-injected to determine partial loss of
each gene could phenocopy the loss of each gene individually. Co-
injection of suboptimal doses of morpholino resulted in delayed
angioblast sprouting with an average of 5.2 (±5.2) sprouts per
embryo (n= 70), while uninjected controls had an average of 15.3
(±2.0) sprouts per embryo (n= 71) (Figs. 3H, I). Each morpholino
alone showed no phenotype at these doses (data not shown). These
data provide strong evidence for a genetic interaction between
Sema3e and PlxnB2.
PlxnD1 and PlxnB2/Sema3e act antagonistically to control timing of
angioblast sprouts
Loss of PlxnD1 or Sema3e has opposite effects on timing of
angioblast sprouting. To investigate if Sema3e and PlxnD1 antagonize
each other we downregulated PlxnB2 and Sema3e in obd mutant
Fig. 3. Angioblast sprouting is delayed in plxnB2i10e11 and plxnB2i10e11/sema3eATG morphants. (A–B) PlxnB2 expression analysis by in situ hybridization shows semi-ubiquitous
expressionwith ventral enrichment in the region surrounding the axial vessels inwholemount (A) and cross section views (B). The dashed line in A indicates the level of the section in
B. (C–D)White light images of control (C) and plxnB2i10e11morphant (D) at 24 hpf. (E–H) Confocal images of uninjected (E), plxnB2i10e11morphant (F), sema3eATGmorphant (G), and
plxnB2i10e11/sema3eATGmorphant (H) at 24hpf on a Tg(kdr:GFP)la116 genetic background. (I) Graphical representation of themean number and standard deviation of angioblast sprouts
observed in plxnB2i10e11 morphants, sema3eATG morphants, and plxnB2i10e11/sema3eATG morphants as compared to control embryos. Scale bar in A, C–H is 100 μm and 30 μm in B.
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fs31-l and fv109k alleles are functional nulls for PlexinD1 and are
indistinguishable (Torres-Vazquez et al., 2004), and thus if PlxnB2 and
PlxnD1 act in the same pathway, there should be no change in the obd
phenotype when PlxnB2 expression is lost in the same animal.
Down-regulation of plxnB2 in obd mutant embryos resulted in an
additive phenotype with fewer angioblast sprouts (7.0±5.7; n= 44)
than in uninjected obd mutants (21.8±2.0; n= 43) (Figs. 4A, C, E).Similarly, loss of Sema3e in obd mutant embryos resulted in fewer
sprouts (10.6±2.5; n= 58) than uninjected obdmutants (20.2±1.8;
n= 62). Notably, loss of Sema3e in obd mutants resulted in more
angioblast sprouts than loss of Sema3e in their wild type sibs
(10.6±2.5 versus 3.9±1.7 sprouts, respectively; Figs. 4B, D, F). Similar
to our previous results, injection of sema3eATG morpholino into obd
wild type sibs also resulted in delayed angioblast sprouting (3.9±1.7;
n= 37) compared to uninjected wild type sibs (16.6±1.1; n= 44) at
Fig. 4. Loss of plxnD1 and sema3e/plxnB2 results in an intermediate angioblast sprouting phenotype (A) Graphical representation of the mean number and standard deviation of
angioblast sprouts observed in plxnB2i10e11/obdmorphants as compared to control obdmutant embryos. (B) Graphical representation of the proportion of embryos exhibiting a given
number of ISVs sprouts in uninjected obdwt sibs, sema3eATGMO/obdwt sib morphants, uninjected obdmutant embryos, and sema3eATG MO/obdmorphants. (C–F) Confocal images
of uninjected obd mutant (C), uninjected wt sibs (D), plxnB2i10e11/obd morphants (E), and sema3eATG/obd morphants (F) at 24 hpf on a Tg(kdr:GFP)la116 genetic background. Scale
bars in (C–F) are 100 μm.
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PlxinB2/Sema3e are lost in the same animal suggests that signalling
from each receptor is distinct and that signalling downstream of each
receptor likely antagonizes signalling from the other receptor.
Sema3e and PlxnB2 act autonomously in angioblasts
To further investigate the role of Sema3e and PlxnB2 in angioblast
interactions, we sought to over-express Sema3e using the angioblast
lmo2 promoter (Zhu et al., 2005). However, injection of sema3e RNA
or lmo2:sema3e-IRES-GFP DNA resulted in complete, early embryonic
lethality (data not shown) which precluded us from determining the
role of increased levels of Sema3e on angioblast behaviour. Injection of
the control plasmid lmo2:GFP-IRES-GFP under the same conditions did
not affect embryo survival (data not shown), suggesting that Sema3e
itself is toxic at high levels. Consistent with this, relatively little
morpholino is required for complete knockdown of sema3e. Since it
was not technically feasible to over-express Sema3e in angioblasts,
and there is no method for endothelial-speciﬁc deletion of genes in
zebraﬁsh, we undertook transplant analysis to determine the cell
autonomy of Sema3e.
Previous data suggests that class 3 semaphorins can act cell
autonomously on endothelial cells in culture (Serini et al., 2003). We
hypothesized that if Sema3e was acting cell autonomously, transplan-
tation of sema3emorphant angioblasts intowild type recipientswould
show delayed ISV sprouting, identical to that of sema3emorphants. Assuch, we predicted that few sema3e morphant cells would contribute
to the ISVs and instead would remain in the region of the dorsal aorta.
Conversely, we hypothesized that wild type angioblasts transplanted
into a sema3e morphant recipient would act identical to wild type
angioblasts transplanted into a wild type recipient.
When wild type Tg(kdr:GFP)la116 angioblasts were transplanted
into wild type recipients, 59.1% of cells contributed to the dorsal aorta,
while the remaining 40.9% contributes to the ISVs (n= 342 cells from
26 embryos; Figs. 5A, C)). Transplanted donor cells were also labelled
with rhodamine-dextran to track the destination of donor cells and
sort for embryos with few transplanted cells of endodermal or
ectodermal origin, to remove possible sources of non-autonomous
sema3e (Supplemental Fig. 3). As expected, transplantation of se-
ma3eATG morphant Tg(kdr:GFP)la116 angioblasts into wild type reci-
pients resulted in a substantial increase in the number of cells
contributing to the dorsal aorta (79.8%) and a corresponding decrease
in the number ISV cells (20.2%) (n= 326 from 40 embryos; pb0.001
by Chi-square test; Figs. 5A, E). These results suggest that sema3e acts
cell autonomously in angioblasts.
Surprisingly, however,whenwe transplantwild typeTg(kdr:GFP)la116
angioblasts into sema3eATG morphant recipients, we also found an
increase in cell numbers in the dorsal aorta (74.3% of transplanted
angioblasts), while only 25.7% were ISV cells (n=583 cells from 43
embryos; pb0.002 by Chi-square test; Figs. 5A, D), suggesting that
Sema3e also acts in a non-cell autonomous manner on angioblasts.
Given that sema3e is a secreted molecule, it is likely that one cell
Fig. 5. Sema3e acts both autonomously and non-autonomously in angioblasts while PlxnB2 acts autonomously. (A) Summary of the total proportion of cell types observed after
transplantation given as a percentage of total cells counted. (B–E) Representative images of a Tg(kdr:GFP)la116 wild type donor embryo (B), recipient embryo from a wtNwt
transplantation (C), recipient embryo from a wtN3e MO transplantation (D), recipient embryo from a 3e MONwt transplantation (E), recipient from a wtNplxnB2 MO
transplantation (F), and recipient from a plxnB2 MONwt transplantation (G). Arrows indicate cells classiﬁed as dorsal aorta (da), ISV cells (ISV). ⁎ denotes a probability of difference
from wild type by Chi-square test of b0.002. Scale bar is 100 μm.
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appearing to act both cell autonomously and non-autonomously.
To investigate if Sema3e–PlxnB2 signalling is required both cell
autonomously, non-autonomously, or both, we transplanted plxnB2
morphant endothelial cells into wild type recipients, as well as wild
type endothelial cells into plxnB2 morphant recipients, and deter-
mined their contribution to either the dorsal aorta of ISV as above.Transplantation of wild type Tg(kdr:GFP)la116 angioblasts into
plxnB2i10e11 morphant recipients resulted in a cell distribution similar
to that observed in control wild type to wild type experiments with
61.5% of cells contributing to the dorsal aorta and 38.5% of cells
contributing to the ISVs (n= 234 cells from 19 embryos; not
signiﬁcantly different from wtNwt transplants by Chi-square test;
Figs. 5A, F). Conversely, when plxnB2i10e11 morphant Tg(kdr:GFP)la116
207R.E. Lamont et al. / Developmental Biology 331 (2009) 199–209angioblasts were transplanted into wild type recipients, we observed
85.5% of angioblasts contributed to the dorsal aorta, while only 14.5%
of plxnB2 morphant angioblasts contributed to ISVs (n= 179 cells
from 20 embryos; p b0.001 by Chi-square test; Figs 5A, G), similar to
results observed for sema3e morphants.
Discussion
Sema3e controls the timing of intersegmental vessel sprouting
independently of PlxnD1
We have uncovered a new role for Sema3e in zebraﬁsh vascular
development and present genetic evidence that Sema3e acts primarily
through PlxnB2, and not PlxnD1, to control the timing of angioblast
sprouting. Previous in vitro and in vivo work in mouse has shown that
Sema3e is repulsive to angioblasts, and is a ligand for the plexin
receptor, PlxnD1 (Gu et al., 2005). Thus, we hypothesized that
zebraﬁsh sema3e morphants would share the same vascular pheno-
type as obd mutants. However, this is not the case as sema3e
morphants show delayed angioblast sprouting while obd mutant
embryos show precocious sprouting. This suggests that Sema3e plays
a novel additional role in vascular development in the control of
angioblast migration, independently of its interaction with PlxnD1.
The differences between the Sema3e knockdown/knockout pheno-
types in mouse and ﬁsh could be attributed to species differences in
expression and function. Sema3e has not been reported to be
expressed in vessels in mice although it is expressed in the motor
domain of the neural tube, in non-neural mesenchyme between the
neural tube and dorsal root ganglia at embryonic day (E) 12.5, and in
the caudal somite at E11.5 (Gu et al., 2005) (Miyazaki et al., 1999b; Zou
et al., 2000). With the exception of motor domain expression, we do
not ﬁnd overlapping expression in the ﬁsh. In zebraﬁsh sema3e is
expressed by the large vessels of the trunk, the ISVs, and in the
endoderm beneath the pronephric ducts. We ﬁnd that the level of
vascular expression of sema3e is weaker than its motoneuron
expression in zebraﬁsh, and perhaps further analysis of Sema3e
expression in mice will also ﬁnd it expressed at low levels in vessels.
PlxnB2 genetically interacts with Sema3e to control timing of
angioblast sprouting
Since PlxnD1 did not appear to be the receptor for Sema3e in
timing angioblast sprouting, we performed an expression screen of all
previously uncharacterized zebraﬁsh plexins. Previously, PlxnB2
expression was identiﬁed in human umbilical vein endothelial cells
in culture (Toyofuku et al., 2007) and here we show that plxnB2 is
expressed ubiquitously. plxnB2 morphants exhibit a phenotype
identical to that of sema3e morphants with severely delayed
angioblast sprouting, suggesting that PlxnB2 might be the receptor
for Sema3e in controlling timing of angioblast sprouting. Further, co-
injection of sub-optimal doses of morpholinos for sema3e and plxnB2
results in the same delayed angioblast sprouting phenotype as for full
doses of each morpholino-injected alone. These data suggest that
PlxnB2 could act as a receptor for Sema3e in sprouting angioblasts.
Antagonism among PlxnB2, PlxnD1 and Sema3e
To understand the relationship between PlxnB2 and PlxnD1 in
controlling ISV development, we manipulated sema3e levels in obd/
PlxnD1 genetic mutants. If Sema3e and/or PlxnB2 were acting in the
same pathway as PlxnD1, we would expect to see no additional
exacerbation of the obd phenotype when expression of Sema3e or
PlxnB2 is lost in obd/PlxnD1 mutants. This is not the case as we
observe a delay in angioblast sprouting when expression of Sema3e or
PlxnB2 is lost in obd/PlxnD1 mutants. This delay is less than the delay
of sema3e or plxnB2 morphants in a non-obd genetic background, butmore thanwild type animals or obdmutants, and thus is intermediate.
Therefore PlxnB2 and PlxnD1 likely use independent and opposing
signalling pathways to control the timing of angioblast exit.
Sema3e inﬂuences angioblast sprouting in both a cell autonomous
and non-autonomous manner
Although previous studies have demonstrated Sema3e expression
in cultured endothelial cells (Christensen et al., 2005; Serini et al.,
2003), our study is the ﬁrst to identify sema3e expression within
blood vessels in vivo, and points to a novel role for Sema3e in vascular
development. Semaphorin–plexin signalling typically involves non-
autonomous interactions between a ligand expressed in the environ-
ment and a plexin receptor expressed on a migratory cell. Indeed,
PlxnD1 expressed on angioblasts appears to interact with Sema3ab
expressed by somites to pattern the direction of ISV growth in
zebraﬁsh (Torres-Vazquez et al., 2004).
However, ours is the ﬁrst example of a semaphorin playing an
autonomous role in timing of angioblast sprouting. Cell autonomous
roles for semaphorins are only recently being uncovered. Sema3a is
expressed in newly forming vessels where it plays a role in adhesion of
endothelial cells to different substrates (Serini et al., 2003), while
Sema3c expressed by glomerular endothelial cells plays an autocrine
role in cell proliferation, adhesion, tube formation, and VEGF120
secretion (Banu et al., 2006). Further, semaphorin expression cell
autonomously inﬂuences other developmental processes such as
salivary gland cleft formation (Chung et al., 2007), lung branching
morphogenesis (Ito et al., 2000; Kagoshima and Ito, 2001), and
podocyte differentiation and survival (Guan et al., 2006).
Our cell transplantation experiments showed that sema3e acts both
cell autonomously and non-autonomously in angioblasts, a seeming
contradiction. sema3e morphant angioblasts transplanted into wild
type recipients have delayed sprouting, suggesting that autocrine se-
ma3e signalling is required during vessel development. But we also
show that sema3e acts non-cell autonomously on angioblasts because
wild type angioblasts transplanted into sema3e morphant recipients
also have delayed sprouting. In contrast, wild type cells transplanted
into wild type embryos have normal sprout timing. In our transplant
experiments the only other sources of Sema3e expression in the
zebraﬁsh embryo were eliminated by pre-sorting for embryos
containing minimal numbers of cells of endodermal or ectodermal
origin. Thus, Sema3e appears to be required by both host and donor
angioblasts for proper angioblast sprouting.
Transplantation of plxnB2 morphant angioblasts into a wild type
environment resulted in delayed angioblast sprouting similar to that
observed for sema3e morphant angioblasts. However, the converse
experiment of transplanting wild type angioblasts into a plxnB2
morphant resulted in angioblasts migrating in a pattern similar to
those observed in wild type experiments, suggesting that plxnB2 acts
cell autonomously to control the timing of angioblast sprouting. This is
not surprising given that PlxnB2 is a transmembrane receptor
anchored to the expressing cell, and would be expected to act only
on the cell to which it is tethered. We propose that angioblasts
forming the ISVs are in physical contact with other angioblasts in the
dorsal aorta prior to sprouting and express the PlxnB2 receptor. Our
data suggest that a sufﬁciently high and additive level of Sema3e
expression from the local ‘community’ of angioblasts within a sprout
is required to control the timing of sprouting. If any cell within a
sprout lacks Sema3e, the migration of the whole sprout is delayed.
A model for the interactions among semaphorin/plexin signalling in
ISV development
VEGF is the primary inductive signal for ISV sprouting and is
expressed several hours before the ﬁrst sprouts appear. Plexin–
semaphorin signalling on the other hand, modulates the timing and
208 R.E. Lamont et al. / Developmental Biology 331 (2009) 199–209path of sprouting (Covassin et al., 2006; Lawson et al., 2003;
Nasevicius et al., 2000). We have previously shown that the guidance
of ISV growth is regulated by the non-autonomous interaction of
endothelially-expressed PlxnD1 and somite-expressed semaphorins,
such as Sema3a2. Further, PlexinD1 also represses ISV sprouting since
out of boundsmutant embryos have precocious sprouting (Childs et al.,
2002; Torres-Vazquez et al., 2004). Here we show that the promotion
of sprouting is regulated by the interaction of endothelially-expressed
Sema3e and endothelially-expressed PlxnB2. Since PlxnD1 and PlxnB2
have apparently antagonistic effects on the timing of sprouting, do
both receptor signalling pathways act in parallel to converge on the
same downstream signalling molecules or does the activation of one
receptor modify the signalling of the other? Plexin family members
interact with, and signal through, small GTPases of the Rnd and R-Ras
families to modify integrin adhesion (Oinuma et al., 2004; Uesugi et
al., 2009). While PlxnB2 interacts with Rnd1, PlxnD1 interacts with
Rnd2 (Chardin, 2006). The interactions between Rnd1 or Rnd2 and R-
Ras are not completely elucidated, but if they had differing abilities to
activate R-Ras, this would provide a possible direct mechanism for
how PlxnB2 and PlxnD1 signal antagonistically.
There is also precedent for modulation of sensitivity in semaphorin
signalling. Overexpression of Sema3A within chick spinal motoneur-
ons desensitizes their growing axons to environmental Sema3A,
allowing inappropriate axon growth into regions normally repulsive
to these axons. Further, loss of Sema3A in these axons makes axons
highly sensitive to environmentally expressed Sema3A (Moret et al.,
2007). The striking delay of angioblast sprouting observed in sema3e
morphants could result from increased sensitivity of angioblasts
lacking Sema3e to repulsive cues expressed in the environment such
as Sema3a. Future experiments will allow us to distinguish the precise
mechanism by which the two receptors modulate each other's
signalling to ﬁnely tune the timing of angiogenic sprouting.
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